Current Report Filing (8-k)
May 16 2022 - 09:31AM
Edgar (US Regulatory)
0001353406 false 0001353406 2022-05-16
2022-05-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date
of Report (Date of Earliest Event Reported):
May 16, 2022
REDHAWK HOLDINGS CORP.
(Exact
name of registrant as specified in its charter)
|
Nevada |
000-54323 |
20-3866475 |
| (State
or other jurisdiction of incorporation) |
(Commission
File Number) |
(I.R.S.
Employer Identification No.) |
| |
|
|
|
100 Petroleum Drive Suite 200,
Lafayette,
Louisiana 70508 |
| (Address
of principal executive offices) (Zip Code) |
Registrant’s
telephone number, including area code: (337)269-5933
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act: None.
Indicate
by check mark whether the registrant is an emerging growth company
as defined in Rule 405 of the Securities Act of 1933 (§230.405 of
this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§240.12b-2 of this chapter).
Emerging
growth company ☐
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange
Act. ☐
The
Registrant confirmed today that it is in discussions with a leading
healthcare provider (“Provider”) of pharmaceutical care and
clinical services in the United States with the mutual objective
(i) to reach an agreement to install the Registrant’s SANDD
Pro™ needle incineration devices in each of the Provider’s
pharmacies and clinics in order to reduce the Provider’s needle
disposal costs and eliminate incidents of workplace needle stick
injuries; and (ii) to reach an agreement for the Provider to offer
to the public in each of its pharmacies the over-the-counter “white
label” sale of the Registrant’s SANDD mini™.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this Report to be signed on its behalf
by the undersigned, hereunto duly authorized.
| |
REDHAWK HOLDINGS CORP. |
| |
|
| Date:
May 16, 2022 |
By: |
/s/
G. Darcy Klug |
| |
|
G.
Darcy Klug |
| |
|
Chief
Financial Officer |
RedHawk (CE) (USOTC:SNDD)
Historical Stock Chart
From Jul 2022 to Aug 2022
RedHawk (CE) (USOTC:SNDD)
Historical Stock Chart
From Aug 2021 to Aug 2022
